Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis

Minh Dang Nguyen1, Jean-Pierre Julien

  • 1Department of Pathology, Harvard Medical School, Boston, Mass. 02115, USA. minh-dang_nguyen@hms.harvard.edu

Neuro-Signals
|December 16, 2003
PubMed

Insights

Amyotrophic lateral sclerosis (ALS) involves motor neuron damage. The serine/threonine-cyclin-dependent kinase 5 (Cdk5) and its co-activators play a role in ALS neurodegeneration.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Neuropathology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease impacting motor neurons in the brain and spinal cord.
  • The serine/threonine-cyclin-dependent kinase 5 (Cdk5) pathway is increasingly implicated in neurodegenerative disorders.
  • Dysregulation of Cdk5 has been observed in the context of ALS pathogenesis.

Purpose of the Study:

  • To review current findings on the role of Cdk5 in ALS.
  • To explore the mechanisms by which Cdk5 contributes to motor neuron degeneration.
  • To propose novel perspectives for understanding Cdk5-induced neurodegeneration in ALS.

Main Methods:

  • Literature review of existing research on Cdk5 and ALS.
  • Analysis of studies investigating Cdk5 co-activators (p25, p29) in neurodegeneration.
  • Synthesis of evidence linking Cdk5 activity to altered protein phosphorylation and cell cycle regulation.

Main Results:

  • Emerging evidence links Cdk5 to the pathogenesis of ALS.
  • Truncated Cdk5 co-activators, p25 and p29, contribute to neurodegeneration.
  • Altered phosphorylation of cytosolic and cytoskeletal proteins is a key mechanism.

Conclusions:

  • Cdk5 dysregulation is a significant factor in ALS neurodegeneration.
  • Understanding Cdk5-mediated mechanisms offers new therapeutic avenues for ALS.
  • Further research into Cdk5's role is crucial for deciphering ALS pathogenesis.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...